Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-24 @ 2:12 PM
NCT ID:
NCT06731595
Eligibility Criteria:
Inclusion criteria:
\- All patients \>/= 18 undergoing atrial fibrillation ablation
Exclusion Criteria:
* Patients unable to receive or tolerate colchicine
* Pregnant or lactating women
* Concomitant use of drugs interacting with colchicine (including: cyclosporin, ranolazine, tacrolimus, clarithromycin, indinavir, itraconazole, ketoconazole, nefazadone, ritonavir, saquinavir, suboxone, telithromycin, erythromycin, fluconazole, verapamil, diltiazem, or more than 1 glass grapefruit juice daily)
* Severe renal impairment (CrCl \< 30 mL/min)
* Severe hepatic impairment (ALT/AST greater than 5x ULN or clinical cirrhosis)
* Ongoing current use of colchicine.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06731595
Study Brief:
Protocol Section:
NCT06731595